Related Experiment Video
Updated: May 8, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Patient outcome after complete surgery for retroperitoneal sarcoma
Carlo Riccardo Rossi1, Andrea Varotto, Sandro Pasquali
1Via Giustiniani, 2, 35128 Padova, Italy. pasqualisandro@hotmail.com.
Anticancer Research
|September 12, 2013
Summary
Complete surgery offers better outcomes for patients with primary retroperitoneal sarcoma (RS). Recurrent tumors and high-grade disease increase local recurrence risk, impacting survival after aggressive surgical resection.
Area of Science:
- Oncology
- Surgical Oncology
- Sarcoma Research
Background:
- Retroperitoneal sarcoma (RS) treatment often involves aggressive surgery for local tumor control.
- Investigating survival outcomes after complete surgical resection is crucial for RS management.
Purpose of the Study:
- To evaluate local disease-free survival and overall survival in patients with retroperitoneal sarcoma (RS) following complete surgical resection.
- To identify prognostic factors influencing survival and recurrence in RS patients.
Main Methods:
- Retrospective analysis of patients who underwent complete surgery for RS.
- Data extracted from a prospectively maintained database.
Main Results:
- Fifty-five percent of patients (43/78) had primary RS; 54% (42/78) underwent resection of infiltrated organs.
- Recurrent tumors (HR=5.57) and high-grade tumors (HR=3.47) were associated with higher local recurrence risk.
- Microscopically involved margins (HR=3.47) and recurrent tumor at presentation (HR=2.49) independently predicted poor survival.
Conclusions:
- Complete surgery is the standard of care for primary retroperitoneal sarcoma.
- Patients with primary RS demonstrate superior local disease-free and overall survival compared to those with recurrent tumors post-complete surgery.